Great Point Partners LLC Moon Lake Immunotherapeutics Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$11.03 - $23.7 $4.02 Million - $8.63 Million	-364,232 Reduced 56.68%	278,334 $5.95 Million
Q4 2022 Feb 14, 2023	BUY	$7.05 - $10.5 $1.06 Million - $1.58 Million	150,566 Added 30.6%	642,566 $6.75 Million
Q3 2022 Nov 14, 2022	BUY	$5.25 - $9.27 $315,000 - $556,200	60,000 Added 13.89%	492,000 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$4.69 - $13.25 $2.03 Million - $5.72 Million	432,000 New	432,000 $2.27 Million

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2.01B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.